Recent Finacing
Recent Raise
Hyperion Therapeutics is a specialty biopharma developing and commercializing gastrointestinal and hepatology therapies for urea cycle disorders and hepatic encephalopathy, marketing AMMONUL and BUPHENYL, and advancing GT4P.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
